Article Details

Moderna Announces First Participant Dosed in Phase 1 Study of its HIV Trimer mRNA ...

Retrieved on: 2022-03-19 16:34:48

Tags for this article:

Click the tags to see associated articles and topics

Moderna Announces First Participant Dosed in Phase 1 Study of its HIV Trimer mRNA .... View article details on hiswai:

Excerpt

CAMBRIDGE, Mam USA I March 14, 2022 I Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up